NEW YORK (GenomeWeb) – KromaTid today announced a Japanese distribution agreement with Tokyo Future Style for its directional Genomic Hybridization (dGH) and Pinpoint FISH products and services.
"Tokyo Future Style has a very focused approach to the Japanese market that we feel makes them a great fit for selling our products and services," KromaTid CEO Alex Vodenlich said in a statement.
The firm's dGH genomic imaging assay is able to determine DNA sequence, location, and orientation data in a single test, the firm said in a statement.
Financial and other terms of the agreement were not disclosed.
In February, Fort Collins, Colorado-based KromaTid inked a European distribution agreement with Tebu-bio.